Combination Radiation Therapy and Imipridone ONC201 for the Treatment of Solid Tumors

被引：1
|
作者：
Jhawar, S. R. [1 ]
Goyal, S. [2 ]
Thandoni, A. [1 ]
Wu, H. [1 ]
Hassan, S. [3 ]
Schiff, D. S. [1 ]
Allen, J. [4 ]
Stogniew, M. [4 ]
Tarapore, R. [4 ]
Stein, M. [1 ]
Bertino, J. [1 ]
Haffty, B. G., Jr. [1 ]
Zloza, A. [1 ,5 ]
机构：
[1] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA
[2] Rutgers Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USA
[3] Rutgers State Univ, New Brunswick, NJ USA
[4] Oncoceutics Inc, Philadelphia, PA USA
[5] Rutgers Robert Wood Johnson Med Sch, Dept Surg, New Brunswick, NJ USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2017年 / 99卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2017.06.2041
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3424
引用
收藏
页码：E598 / E598
页数：1
相关论文
共 50 条
  • [31] Preclinical evaluation of imipridone ONC201 in triple negative breast cancer identifies predictive biomarkers and combinatorial opportunities
    Lim, Bora
    Lee, Jangsoon
    Liu, Huey
    Pearson, Troy
    Coffer, Larry
    Tripathy, Debu
    Ueno, Naoto T.
    CANCER RESEARCH, 2017, 77
  • [32] The Imipridone ONC201 Induces Apoptosis and Overcomes Chemotherapy Resistance by Up-Regulation of Bim in Multiple Myeloma
    Tu, Yong-Sheng
    He, Jin
    Liu, Huan
    Lee, Hans C.
    Wang, Hua
    Ishizawa, Jo
    Allen, Joshua E.
    Andreeff, Michael
    Orlowski, Robert Z.
    Davis, Richard E.
    Yang, Jing
    NEOPLASIA, 2017, 19 (10): : 772 - 780
  • [33] Anti-tumor effects of imipridone ONC201 in combination with anti-angiogenic agents significantly impact on colorectal cancer growth in vivo
    Wagner, Jessica
    El-Deiry, Wafik
    CANCER RESEARCH, 2017, 77
  • [34] Clinical activity of the selective DRD2 antagonist ONC201, an imipridone, in metastatic endometrial cancer (mEC).
    Rodriguez-Rodriguez, Lorna
    Mehnert, Janice M.
    Silk, Ann W.
    Chan, Nancy
    Malhotra, Jyoti
    Aisner, Joseph
    Saunders, Tracie
    Yu, Bangning
    Dickerson, Siobhan
    Tarapore, Rohinton
    Allen, Joshua E.
    Stogniew, Martin
    Oster, Wolfgang
    Kaufman, Howard
    Haffty, Bruce George
    Bertino, Joseph R.
    Stein, Mark N.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [35] Combination of ONC201 with radiation exhibits synergistic efficacy in high grade gliomas and other advanced cancers
    Tarapore, Rohinton S.
    Jhawar, Sachin
    Stein, Mark
    Zloza, Andrew
    Mueller, Sabine
    Zhang, Jie
    Amoroso, Francesca
    Mills, Ian
    Oster, Wolfgang
    Allen, Joshua
    CANCER RESEARCH, 2019, 79 (13)
  • [36] Differentiated pharmacology of the imipridone ONC201: the first selective DRD2/3 antagonist in clinical oncology
    Madhukar, Neel S.
    Prabhu, Varun Vijay
    Anantharaman, Lakshmi
    Sulli, Chidananda
    Davidson, Edgar
    Deacon, Sean
    Rucker, Joseph
    Charter, Neil
    Doranz, Benjamin
    Oster, Wolfgang
    Elemento, Olivier
    Free, R. Benjamin
    Sibley, David
    Allen, Joshua E.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [37] First-in-human dose escalation study of oral ONC201 in advanced solid tumors.
    Stein, Mark N.
    Mayer, Tina M.
    Moss, Rebecca Anne
    Silk, Ann W.
    Chan, Nancy
    Haffty, Bruce George
    DiPaola, Robert S.
    Beckett, Yasmeen
    Bentlyewski, Edward
    Zheng, Ling
    Fang, Bruno
    Allen, Joshua
    Mehnert, Janice M.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [38] Anti-tumorigenic effect of combination treatment with ONC201 and TRAIL in endometrial cancer in vitro and in vivo
    Ray, J.
    Ralff, M.
    Jhaveri, A.
    El-Deiry, W.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 76 - 77
  • [39] Synergistic combination therapy with ONC201 or ONC206, and enzalutamide or darolutamide in preclinical studies of castration-resistant prostate cancer
    Wu, Laura Jinxuan
    Pinho-Schwermann, Maximilian
    Zhou, Lanlan
    Zhang, Leiqing
    Huntington, Kelsey E.
    Malpass, Ryan
    Seyhan, Attila A.
    Carneiro, Benedito A.
    El-Deiry, Wafik S.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (12): : 6012 - 6036
  • [40] Targeting DRD2 dysregulation in recurrent glioblastoma with imipridone ONC201: predictive and pharmacodynamic clinical biomarker analyses
    Prabhu, Varun Vijay
    Madhukar, Neel
    Kline, C. Leah B.
    Tarapore, Rohinton
    El-Deiry, Wafik
    Elemento, Olivier
    Doherty, Faye
    VanEngelenburg, Alexander
    Durrant, Jessica
    Zloza, Andrew
    Benes, Cyril
    Arrillaga, Isabel
    Oster, Wolfgang
    Allen, Joshua E.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
12345